Editor(s):
(1) Dr. Angelica Machi Lazarin, Associate Professor, State University of Maringa, Brazil.
Reviewers:
(1) L Srividya, Vaagesgeshwari Institute of Pharmaceutical Sciences, India.
(2) K. Harika Priyadarshini, Guntur Medical College, India.
Additional Reviewers:
(1) Abatur Suleiyol Charity, Federal Medical Center, Nigeria.
(2) Ali Abdullahi Damasak, University of Maiduguri, Nigeria.
(3) Johnbasha.Shaik, NIMRA Institute of Medical Sciences, India.
(4) Mallesha L, JSS College of Arts, Commerce and Sciecne, India.
(5) Meena Anand K, Manipal University College Malaysia, Malaysia.
(6) Ravi Babu Surisetti, Andhra University, India.
(7) R.Baskar, The Tamilnadu DR.M.G.R Medical University, India.
(8) Sefi Mediha, Higher Institute of Biotechnology of Sidi Thabet, Tunisia.
Additional Reviewers: (Comments received after deadline)
(1) Ali Khgarazmkia, Lorestan University of Medical Sciences, Iran.
(2) Prathiba H.D, Bangalore University, India.
(3) Vibha Dwivedi, National Institute of Health (NIH), USA.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 7.9/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (L Srividya, India) | File 1 | NA
Stage 2 | Peer Review Report_2 (K. Harika Priyadarshini, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA